4d Molecular Therapeutics

This late-stage trial is testing whether a single injection of an experimental gene therapy called 4D-150 can control vision loss from wet age-related macular degeneration (AMD). It aims to see if this one-time treatment can reduce or eliminate the need for the frequent eye injec…

This study is testing a one-time gene therapy injection (called 4D-150) for adults with diabetic macular edema, a condition that causes swelling and vision loss. The goal is to see if this single treatment can safely reduce the need for the frequent eye injections patients curren…